Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield

Novel engineered T cells containing chimeric antigen receptors (CAR-T cells) that combine the benefits of antigen recognition and T cell response have been developed, and their effect in the anti-tumor immunotherapy of patients with relapsed/refractory leukemia has been dramatic. Thus, CAR-T cell im...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Yuna, Ali, Laraib Amir, Shim, Ju A, Lee, Byung Ha, Hong, Changwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464778/
https://www.ncbi.nlm.nih.gov/pubmed/32731404
http://dx.doi.org/10.3390/cancers12082087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464778/
https://www.ncbi.nlm.nih.gov/pubmed/32731404
http://dx.doi.org/10.3390/cancers12082087

Ejemplares similares